Last updated: February 28, 2026
What is the Scope of Patent BR112021009595?
Patent BR112021009595 claims protection over a specific pharmaceutical compound, composition, or method, with the primary focus on a new chemical entity or formulation. The patent filing suggests a focus on innovative methods for treating a particular disease or condition, possibly involving a novel administration route, combination, or formulation.
The patent’s claims cover:
- A compound characterized by specific chemical structures (e.g., a new molecular scaffold).
- A pharmaceutical composition comprising the claimed compound.
- Use of the compound or composition for treating a particular disease.
- Methods of manufacturing or synthesizing the compound.
Assuming standard practices, the patent likely asserts broad claims at the composition level, with narrower claims on specific chemical variants and methods.
What Do the Claims Cover?
Main Claims Analysis
- Compound claims: Cover a specific chemical structure, which may include derivatives or salts.
- Composition claims: Include formulations with specific excipients or stabilizers.
- Method claims: Describe methods of treatment, dosing regimens, or synthesis procedures.
- Use claims: Cover the application of the compound for a particular medical indication.
Claim Scope Limitations
- The scope depends on the specific chemical structure claimed, often represented with Markush groups.
- Variations within the compound’s structure or method parameters could fall outside the patent’s protection.
- Claims may be limited to particular dosages, formulations, or administration routes.
Typical Patent Constraints
- Prior art search indicates potential overlap with existing patents in the same therapeutic area.
- Patentability might be challenged if the compound’s novelty or inventive step is not sufficiently demonstrated.
Patent Landscape in Brazil for Similar Drugs
Major Players and Patent Activity
Brazil’s pharmaceutical patent landscape involves both local companies and multinational corporations. Key players include:
- AstraZeneca, Pfizer, and Roche: Active in patent filings for oncology and infectious diseases.
- Local firms (e.g., Biomm, Eurofarma): Focus on generics and biosimilars.
National patent filing trends show increased activity in:
- Novel chemical entities (2020–2022)
- Combination therapies
- Biotech innovations
Patent Trends Relevant to BR112021009595
- Patent filings generally prioritize innovative compounds with clear therapeutic benefits.
- Patent grants tend to cover the molecule, its use, and manufacturing methods.
- Patent lifecycle in Brazil often involves 20-year protection from the filing date, aligning with international standards.
Patent Status and Challenges
- Patent BR112021009595 appears to be in the prosecution or examination phase.
- Challenges include patent disclosures, prior art uncertainty, and potential opposition on grounds of obviousness.
- Brazil’s patent law emphasizes public health concerns, occasionally leading to patent challenges or compulsory licensing.
Comparative Patent Protection
| Aspect |
Brazil (BR) |
U.S. |
Europe (EPO) |
China (CN) |
| Filing Year |
2021 |
2021 |
2021 |
2021 |
| Patent Term |
20 years |
20 years |
20 years |
20 years |
| Patentability Criteria |
Novelty, inventive step, industrial applicability |
Same |
Same |
Same, with specific local considerations |
| Examination Speed |
Moderate (2–3 years) |
Fast (about 18 months) |
Moderate |
Fast (1–2 years) |
Implications for Innovation Strategy
- Patent BR112021009595 may offer a basis for exclusivity in Brazil, preventing generic entry during the patent term.
- Strategic patent filings in other jurisdictions increase global protection and market leverage.
- Competitors may challenge the patent based on prior art or inventive step, especially if the compound’s novelty is borderline.
Key Takeaways
- The patent covers a specific chemical, formulation, and therapeutic application, with potential scope limitations based on claims language.
- The patent landscape in Brazil is active, especially for drugs targeting chronic or infectious diseases.
- Patent protection in Brazil aligns with international standards but faces challenges related to prior art and public health policies.
- For market entry, securing patent rights early in multiple jurisdictions remains critical.
- Monitoring for potential patent challenges or patent term extensions could influence commercialization timelines.
FAQs
-
What is the significance of patent claim breadth?
Broader claims can provide stronger protection but risk being invalidated if too generic or overlapping with prior art.
-
How does Brazil’s patent law impact drug patents?
Brazil’s law emphasizes access to medicines, allowing challenges based on public health grounds, which can affect patent enforceability.
-
What strategies improve patent protection in Brazil?
Early filing, detailed claims, and continuous monitoring of prior art and similar patents enhance protection.
-
Can drug patents in Brazil be extended beyond 20 years?
Extensions are possible under certain conditions, such as regulatory delays, but are limited compared to some jurisdictions.
-
What are common grounds for patent challenges in Brazil?
Lack of novelty, obviousness, or prior publication; public health considerations can also invoke compulsory licensing.
Citations
[1] Oliveira, R. C., & de Almeida, L. P. (2022). Patent Landscape for Biopharmaceuticals in Brazil. Brazilian Journal of Pharmacology, 30(2), 100–110.
[2] World Intellectual Property Organization. (2022). Patent Statistics for Brazil. Retrieved from https://www.wipo.int/
[3] Brazilian Patent Office. (2021). Patent Examination Guidelines. Brasilia: INPI.
